Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Multiple studies on breast cancer presented at clinical oncology meeting
June 16th, 2005
Genomic Health, Inc., announced that results from three independent studies evaluating the Oncotype DX breast cancer assay were presented at the 41st annual meeting of the American Society of Clinical Oncology (ASCO). These studies examined the assay's ability to quantify likelihood of recurrence, predict response to chemotherapy, and capture both prognosis and response to tamoxifen in a large portion of early stage breast cancer patients. Initial findings from these studies were presented at the 27th annual San Antonio Breast Cancer Symposium (SABCS). "The fact that these studies continue to gain attention among the oncology community is a...
Source: Women's Health Weekly (2005-06-16)
|
